{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-238307","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2023-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.245565+00:00","generated_at":"2026-06-10T11:46:23.167667+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Elevance Health reaffirms FY 2023 GAAP EPS >$29.09 and adjusted EPS >$32.85","bullets":["Officers reaffirm full-year 2023 GAAP net income >$29.09 per share, including ~$3.76 unfavorable items.","Adjusted net income guidance unchanged at >$32.85 per share, excluding the unfavorable items.","Reaffirmation made during investor meetings over the next ten days; no new adjustments beyond Q2 2023.","Guidance does not reflect any additional items other than those reported in Q2 2023 earnings release."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-238307","json":"https://secwatch.observer/filing/0001193125-23-238307.json","markdown":"https://secwatch.observer/filing/0001193125-23-238307.md","text":"https://secwatch.observer/filing/0001193125-23-238307.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523238307/0001193125-23-238307-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523238307/d523562d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T11:46:23.167667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}